CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 vs Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) is designed for broad, non-invasive screening during routine physical exams, making it highly accessible and easy to integrate into general clinical workflows for a wider range of clinicians. In contrast, CARTOu2122 3, while enhancing complex electrophysiology procedures, requires specialized training and is tailored for a niche user base.

CARTOu2122 3 EP Navigation System Software V8.0 directly impacts complex interventional procedures by providing real-time, AI-powered 3D cardiac mapping and navigation, enhancing diagnosis and treatment of life-threatening arrhythmias. ELEFT offers valuable early detection of low ejection fraction, but its role is primarily a screening tool rather than direct therapeutic intervention.

While both tools have opaque pricing requiring direct sales consultation, Eko's SENSORAu2122 platform, which includes ELEFT, has a clear reimbursement pathway established by CMS with a per-use payment rate of $128.90. This provides a more transparent and defined value proposition for health systems compared to the CARTOu2122 3 system, which represents a significant capital investment with less publicly defined reimbursement details.

Eko Low Ejection Fraction Tool (ELEFT) is explicitly described as part of the SENSORAu2122 Cardiac Early Detection Platform, an 'enterprise solution,' with cloud-based deployment, suggesting easier scalability and management across a large healthcare organization. CARTOu2122 3 is primarily an on-premise system for specialized EP labs, even with its optional cloud data storage, which may present more complex enterprise-wide deployment challenges.

CARTOu2122 3 EP Navigation System Software V8.0 demonstrates a higher degree of innovation by applying AI and deep learning to complex, real-time 3D cardiac mapping, signal analysis, and navigation for interventional electrophysiology procedures. This involves intricate procedural guidance in a highly specialized and high-acuity field. ELEFT, while innovative for screening, applies AI to a less complex diagnostic task.

Eko Health provides a comprehensive and transparent support structure through its SENSORAu2122 Help Center, offering specific guides for various enterprise roles, multiple contact channels (phone, email, chat), and publicly accessible user manuals for ELEFT. While Biosense Webster, as a large company, likely offers robust support, the publicly available documentation for Eko is more detailed and explicit.